The International Journal of Clinical Pharmacology and Therapeutics appears monthly and publishes manuscripts containing original material with emphasis on the following topics: Clinical trials, Pharmacoepidemiology – Pharmacovigilance, Pharmacodynamics, Drug disposition and Pharmacokinetics, Quality assurance, Pharmacogenetics, Biotechnological drugs such as cytokines and recombinant antibiotics. The Journal welcomes papers dealing with cost-benefit aspects of drugs.
Publication Policies
– Publication Ethics and Publication Malpractice Statement: pdf.
– Ethical responsibilities of authors: pdf.
Bioavailability Section
Bioavailability and bioequivalence manuscripts are published in the Bioavailability Section.
Case reports
Case reports on adverse reactions are also of interest.
Short reports
Short reports e.g. of pilot studies on original research will be considered. The length of short reports, including references, should not exceed 1,500 words, with a structured abstract of ~ 100 words and not more than 2 figures or tables or one of each. Any proposed excess over these limitations must be justified by the authors in the covering letter.
Letters to the editor
Letters to the editor can be submitted provided they do not exceed 600 words of text and do not include more than 1 table or 1 figure.
Clinical Trials
Non-registered trials will no longer be accepted with the exception of long-term trials begun before 2002. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study cause and effect relationships of interventions. Trials must register at or before the onset of patient enrollment. Registries that currently meet required standards (e.g., of accessibility, information validation, comprehensive documentation) include:
US National Library of Medicine, www.clinicaltrials.gov – The International Standard Randomised Controlled Trial Number Registry, www.controlled-trials.com – European Clinical Trials Database, www.eudract.emea.europa.eu – The National (UK) Research Register, www.update-software.com/national.
Submission
1. Manuscript: Submit manuscripts online at www.ijcpt.dustri-manus.com (for more instructions contact [email protected]). Include a covering letter containing the declaration given below. When submitting a manuscript, include a statement that all authors agree to the publication with their signatures.
2. Declaration: The covering letter must contain the statement: “The results presented in this paper have not been published previously in whole or part, except in abstract form”. All authors are required to give signed consent for publication on a separate sheet together with the covering letter. Possible conflicts of interest following publication must be disclosed.
For a sample for the signed consent click here, cover letter here.
3. Copyright: On acceptance of a manuscript/paper for publication, the copyright is automatically transferred to the publisher. Published manuscripts or parts of them may not be translated into other languages, reproduced in any form or recorded on files or in computer systems without written permission of the publisher.
A sample copy for a permission inquiry can be found here.
Fees
1. Processing fee: A manuscript processing fee of US$ 70.00/€ 70.00 (+ VAT for authors from EU countries) will be charged for each manuscript. Authors will be requested to pay the processing fee after receipt of submission. Review will be started after receipt of the processing fee. EXEMPTIONS: On application on an individual basis for a) manuscripts dealing with basic research submitted by clinical and academic establishments or other research institutions and b) all review manuscripts.
2. Exceeding pages: A page fee of US$ 70.00/€ 70.00 (+ VAT for authors from EU countries) for each page will only be charged for those pages in excess of 6 printed pages (1 printed page has ~ 4,000 characters with blanks, plus figures). Exemption on application: See 1) above.
3. Exceeding number of figures: Up to five black and white figures will be printed for free. A fee of US$ 100.00/€ 95.00 (+ VAT for authors from EU countries) for each figure will only be charged for those figures in excess of five figures.
4. Commercial interests: A page fee of US$ 140.00/€ 120.00 (+ VAT for authors from EU countries) for each printed page will be charged for articles reporting research serving commercial interests and financed by pharmaceutical companies.
5. Metaanalysis-studies: A page fee of US$ 140.00/€ 120.00 (+ VAT for authors from EU countries) per printed page will be charged for metaanalysis-studies with commercial value in Drug Development and in Regulatory Processes.
6. Studies revolving around therapy options: A page fee of US$ 140.00/€ 120.00 (+ VAT for authors from EU countries) per printed page will be charged for studies revolving around therapy options for registered drugs with commercial value in Drug Development and in Regulatory Processes.
7. Bioavailability studies: A page fee of US$ 220.00/200.00 Euro (+ VAT for authors from EU countries) per printed page will be charged for Bioavailability studies. For more information please contact the publisher at [email protected].
8. Natural products reports: Commencing March 1, 2026 Reports on natural products will be considered for publication in the International Journal of Clinical Pharmacology and Therapeutics (IJCPT). A page fee of US$ 140.00/€ 120.00 (+ VAT for authors from EU countries) per printed page will be charged for studies revolving around Natural products and network pharmacology analysis.
9. Supplemental material: : For supplemental material, a handling fee of US$ 180.00 / € 150.00 (+ VAT for authors from EU countries) will be charged. Supplemental material will be published only online and must be submitted in one file not exceeding 10 MB.
10. Withdrawals: If a manuscript is withdrawn by the authors during the review process, the processing fee mentioned in point 1 will not be waived and will not be reimbursed. If a manuscript is withdrawn after acceptance, a fee of US$140.00 / € 120.00 (+ VAT for authors from EU countries) per typeset page applies in addition to the processing fee.
Manuscripts
1. General: Only manuscripts written in clear, concise English will be accepted. The manuscript should be typed double-spaced on one side of the page only on consecutively numbered pages.
2. Title page: The title should be as concise as possible and begin with a main concept in order to facilitate electronic search. The title page should include the institutions and the full postal addresses of all authors. Each author should be correctly linked to the appropriate address by means of superscripts. The author to whom correspondence should be addressed should also be stated on the title page. Fax, telephone number and Email address must be included. State the contribution of each author to the work being published. A running title should be suggested. State the name of the Trial Register and the Registration Number on the title page. If for any reason the clinical trial is not registered, the reasons for this should be included.
3. Manuscript: The sections of the manuscript should be arranged according to the following sequence: a) Abstract: The abstract should precisely outline objective, materials, methods, results and conclusions and be structured accordingly. It should be comprehensible to readers before they read the paper, key words: For the purpose of documentation, indicate 3 – 5 relevant key words that may or may not appear in the title. They should be given below the abstract and each separated by a dash (–). b) Novelty Statements on 2 aspects: i)What is known about this subject, ii) What this study adds [Statements (up to 3 for each aspect) should be numbered], c) Main text: introduction, methods, materials, patients (or subjects) or case histories, results, discussion, and conclusion, each section being clearly marked. d) Illustrations should be in black and white, color option for payment possible. Legends, tables, references, abstract [~ 1,700 characters with blanks (~ 250 words)] are to be submitted on separate pages.
4. Statements: Funding: All support, financial or otherwise, for any work described should be acknowledged, including support from employing institutions identifiable from the title page. Conflict of Interest statement: Any financial relationship regarding the manuscript from the past three years (dating from the month of submission) of any size, should be declared or disclosed. Use of artificial intelligence: Authors must include a statement regarding the use of artificial intelligence (AI) tools in the preparation of their manuscript if such tools were used. The use of AI solely for linguistic purposes does not require disclosure. Any use of AI for image generation must be disclosed in the statement and in the image caption.
5. Ethnicity: The Int J Clin Pharmacol Ther is a journal serving the international medical community. Since it is well known that the ethnicity of a patient determines the kinetics and action of some drugs and drugs classes, it is becoming essential that authors include a statement describing how this affects their work and conclusions.
6. Language: Non-native English speakers and international authors who would like assistance with their writing before submission can be find a selection of services below. If a manuscript is accepted for scientific merit despite linguistic errors, authors will be requested to improve the language. If requested by the authors, linguistic correction can also be carried out by the publisher for a fee.
Services for scientific editing
a) http:/www.bioscienceeditingsolutions.com.
Bioscience Editing Solutions provides premier scientific editing and translation services for the international community.
b) http://www.journalexperts.com/.
Journal experts specialize in helping international researchers, scientists and scholars to prepare their manuscripts for publication.
c) http://lifescience-editorial.info/.
The staff of Life Science Editorial Ltd. are all native English speakers with extensive experience revising draft English manuscripts for leading medical and biotech researchers at universities as well as for pharmaceutical companies.
d) http://proofreading.org/.
Cambridge Proofreading LTD's editing team includes specialized support for medical authors. We have two native-speaking, fully qualified British doctors with extensive experience editing medical papers by ESL speakers for submission to universities and medical journals.
The staff of Life Science Editorial Ltd. are all native English speakers with extensive experience revising draft English manuscripts for leading medical and biotech researchers at universities as well as for pharmaceutical companies.
Proofs
Authors will be sent page proofs to be checked immediately for typographical errors and returned to the publisher as requested. Costs ensuing from corrections made by the author when these are far in excess of mistakes made by the printer, must be carried by the author.
Style
For style and presentation, authors should consult a recent copy of the journal. All units cited in text and illustration must correspond to the international system of units (SI units). Webster’s Third New International Dictionary is the standard for spelling and compounding. See also Uniform Requirements for Manuscripts Submitted to Biomedical Journals, www.icmje.org.
Illustrations and tables
Submit figures in a computer file (preferred formate: *.tif, resolution 300 dpi). Color photographs can be printed at the author’s expense; price estimate upon request. All photographs and diagrams should be referred to as figures and should be numbered consecutively in the text in Arabic numerals. The legends for illustrations should be typed on a separate sheet. Tables should be numbered consecutively in the text in Arabic numerals and each typed on a separate sheet. The tables must be in a text format (Microsoft Word/Excel or similar). Electronic submission of illustrations is preferred. Please use only Arial font in all figures. For the labeling of graph axes use Arial 10 pt. bold.
Citations
References should be numbered consecutively using Arabic numerals in brackets [..]. The first text reference will be [1]. If a reference is repeated, it keeps the same number. The numbered references list at the end of the manuscript should correspond to the text references.
Limit references to those essential. Papers quoted must be listed in the bibliography. Abbreviations according to Index Medicus.
Examples:
1. Papers published in journals:
[1] ELDesoky ES, Kumar V, Alorainy MS, Hamdi M, Derendorf H. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach. Int J Clin Pharmacol Ther. 2008; 46: 617-626.
2. Books:
[1] Samtleben W, Bosch T, Schönermarck U. Nephrology in a nutshell. Munich – Orlando: Dustri; 2007.
3. Contributions in books:
[1] Luft FC. Erythropoietin and arterial hypertension. In: Hampl H, Riedel E (eds). Cardio renal anemia syndrome. Munich – Orlando: Dustri; 2009. p. 59-62.
Reference Management Software
Authors using EndNote for managing citations and reference lists are welcome to download the “Endnote-style” for “International Journal of Clinical Pharmacology and Therapeutics” at: http://endnote.com/downloads/style/international-journal-clinical-pharmacology-and-therapeutics.
Reprints
Corresponding authors are entitled to 5 copies of the journal free of charge. Larger quantities of reprints can be provided for a fee listed on the reprint order form to be returned with proofs.
